Zydus To Expand Takeda Supply Chain Role, Boost US Sales With CVS Tie-Up
ALS, CAPS Candidate In US Trials
A Zydus-Takeda joint venture is expected to supply more raw materials to the Japanese major. Meanwhile, a tie-up with CVS Caremark for the sitagliptin franchise is a boost for Zydus’s US sales while the company focuses R&D efforts on rare diseases like ALS and CAPS
